960
Views
44
CrossRef citations to date
0
Altmetric
Research Article

Role of Viruses and Other Microbes in the Pathogenesis of Type 1 Diabetes

&
Pages 284-295 | Accepted 06 Jan 2014, Published online: 10 Mar 2014

REFERENCES

  • Atkinson MA. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb Perspect Med 2012;2:1–18.
  • Ziegler AG, Rewers M, Simell O, Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013;309:2473–2479.
  • Patterson CC, Dahlquist GG, Gyürüs E, Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–2020: a multicentre prospective registration study. Lancet 2009;373:2027–2033.
  • Knip M. Descriptive epidemiology of type 1 diabetes—is it still in? Diabetologia 2012;55:1227–1230.
  • Knip M, Veijola R, Virtanen SM, Environmental triggers and determinants of type 1 diabetes. Diabetes 2005;54(Suppl 2):S125–S136.
  • Lohi S, Mustalahti K, Kaukinen K, Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007;26:1217–1225.
  • Alcalde-Cabero E, Almazán-Isla J, García-Merino A, Incidence of multiple sclerosis among European Economic Area populations, 1985–2009: the framework for monitoring. BMC Neurol 2013;13:58.
  • Ng SC, Bernstein CN, Vatn MH, Geographical variability and environmental risk factors in inflammatory bowel disease. Gut 2013;62:630–649.
  • Kondrashova A, Seiskari T, Ilonen J, The ‘Hygiene hypothesis’ and the sharp gradient in the incidence of autoimmune and allergic diseases between Russian Karelia and Finland. APMIS 2013;121:478–493.
  • Strachan DP. Hay fever, hygiene, and household size. BMJ 1989;2996710:1259–1260.
  • Chaparro RJ, Dilorenzo TP. An update on the use of NOD mice to study autoimmune (Type 1) diabetes. Expert Rev Clin Immunol 2010;6:939–355
  • Cooke A, Tonks P, Jones FM, Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 1999;214:169–176.
  • Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911–920.
  • Kondrashova A, Reunanen A, Romanov A, A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann Med 2005;371:67–72.
  • Kondrashova A, Viskari H, Kulmala P, Signs of beta-cell autoimmunity in nondiabetic schoolchildren: a comparison between Russian Karelia with a low incidence of type 1 diabetes and Finland with a high incidence rate. Diab Care 2007;301:95–100.
  • Seiskari T, Kondrashova A, Viskari H, Allergic sensitization and microbial load—a comparison between Finland and Russian Karelia. Clin Exp Immunol 2007;1481:47–52.
  • Kondrashova A, Mustalahti K, Kaukinen K, Lower economic status and inferior hygienic environment may protect against celiac disease. Ann Med 2008;403:223–231.
  • Kondrashova A, Viskari H, Haapala AM, Serological evidence of thyroid autoimmunity among schoolchildren in two different socioeconomic environments. J Clin Endocrinol Metab 2008;933:729–734.
  • Seiskari T, Viskari H, Kondrashova A, Co-occurrence of allergic sensitization and type 1 diabetes. Ann Med 2010;425:352–359.
  • Wen L, Ley RE, Volchkov PY, Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008;455:1109–1113.
  • Giongo A, Gano KA, Crabb DB, Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 2011;5:82–91.
  • Brown CT, Davis-Richardson AG, Giongo A, Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 2011;6:e25792.
  • de Goffau MC, Luopajärvi K, Knip M, Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 2013;62:1238–1244.
  • Murri M, Leiva I, Gomez-Zumaquero JM, Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case–control study. BMC Med 2013;11:46.
  • Araújo-Pérez F, McCoy AN, Okechukwu C, Differences in microbial signatures between rectal mucosal biopsies and rectal swabs. Gut Microbes 2012;3:530–535.
  • Hara N, Alkanani AK, Ir D, Prevention of virus-induced type 1 diabetes with antibiotic therapy. J Immunol 2012;189:3805–3814.
  • Barboni E, Manocchio J. Alterazioni pancreatiche in bovini con diabete mellito post-aftoso. Arch Vet Ital 1962;13:477–489.
  • Jaidane H, Sane F, Gharbi J, Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab Res Rev 2009;25:591–603.
  • Tracy S, Drescher KM. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes. Ann NY Acad Sci 2007;1103:143–151.
  • Yoon JW, Jun HS. Viruses cause type 1 diabetes in animals. Ann NY Acad Sci 2006;1079: 138–146.
  • Rasmussen T, Witsø E, Tapia G, Self-reported lower respiratory tract infections and development of islet autoimmunity in children with the type 1 diabetes high-risk HLA genotype: the MIDIA study. Diabetes Metab Res Rev 2011;7:834–837.
  • Beyerlein A, Wehweck F, Ziegler AG, Pflueger M. Respiratory infections in early life and the development of islet autoimmunity in children at increased type 1 diabetes risk: evidence from the BABYDIET study. JAMA Pediatr 2013;167:800–807.
  • Gale EA. Congenital rubella: citation virus or viral cause of type 1 diabetes? Diabetologia 2008;51:1559–66.
  • Viskari H, Paronen J, Keskinen P, Humoral beta-cell autoimmunity is rare in patients with the congenital rubella syndrome. Clin Exp Immunol 2003;133:378–383.
  • Coppieters KT, Boettler T, von Herrath M. Virus infections in type 1 diabetes. Cold Spring Harb Perspect Med 2012;2:a007682.
  • Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 2010;6:279–289.
  • Racaniello VR. One hundred years of poliovirus pathogenesis. Virology 2006;344:9–16.
  • Palacios G, Oberste MS. Enteroviruses as agents of emerging infectious diseases. J Neurovirol 2005;11:424–433.
  • Tapparel C, Siegrist F, Petty TJ, Kaiser L. Picornavirus and enterovirus diversity with associated human diseases. Infect Genet Evol 2013;14:282–293.
  • Mueller S, Wimmer E, Cello J. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event. Virus Res 2005;111:175–193.
  • Chapman NM, Kim KS. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol 2008;323:275–292.
  • Tam PE, Schmidt AM, Ytterberg SR, Messner RP. Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis. J Lab Clin Med 1994;123:346–356.
  • Feuer R, Ruller CM, An N, Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period. J Virol 2009;83:9356–9369.
  • Green J, Casabonne D, Newton R. Coxsackie B virus serology and type 1 diabetes mellitus: a systematic review of published case-control studies. Diabet Med 2004;21:507–514.
  • Stene LC, Oikarinen S, Hyoty H, Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 2010;59:3174–3180.
  • Tapia G, Cinek O, Rasmussen T, Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study. Diab Care 2011;34:151–155.
  • Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011;342:d35.
  • Oikarinen S, Martiskainen M, Tauriainen S, Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes 2011;60:276–279.
  • Oikarinen M, Tauriainen S, Oikarinen S, Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes 2012;61:687–691.
  • Mercalli A, Lampasona V, Klingel K, No evidence of enteroviruses in the intestine of patients with type 1 diabetes. Diabetologia 2012;55:2479–2488.
  • Smyth DJ, Cooper JD, Bailey R, A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006;38:617–619.
  • von Herrath M. Diabetes: a virus–gene collaboration. Nature 2009;459:518–519.
  • Shigemoto T, Kageyama M, Hirai R, Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J Biol Chem 2009;284:13348–13354.
  • Viskari HR, Koskela P, Lonnrot M, Can enterovirus infections explain the increasing incidence of type 1 diabetes? Diab Care 2000;23:414–416.
  • Roivainen1 M, Ylipaasto P, Savolainen C, Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 2002;45:693–702.
  • Viskari H, Ludvigsson J, Uibo R, Relationship between the incidence of type 1 diabetes and enterovirus infections in different European populations: results from the EPIVIR project. J Med Virol 2004;72:610–617.
  • Viskari H, Ludvigsson J, Uibo R, Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia 2005;48:1280–1287.
  • Richardson SJ, Willcox A, Bone AJ, The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009;52:1143–1151.
  • Oikarinen M, Tauriainen S, Honkanen T, Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia 2008;51:1796–1802.
  • Ylipaasto P, Klingel K, Lindberg AM, Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004;47: 225–239.
  • Gamble DR, Taylor KW, Cumming H. Coxsackie viruses and diabetes mellitus. Br Med J 1973;4:260–262.
  • Gamble DR, Kinsley ML, FitzGerald MG, Viral antibodies in diabetes mellitus. Br Med J 1969;3:627–630.
  • Dotta F, Censini S, van Halteren AG, Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 2007;104:5115–5120.
  • Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979;300:1173–1179.
  • Jenson AB, Rosenberg HS, Notkins AL. Pancreatic islet-cell damage in children with fatal viral infections. Lancet 1980;2:354–358.
  • Yoon JW, London WT, Curfman BL, Coxsackie virus B4 produces transient diabetes in nonhuman primates. Diabetes 1986;35:712–716.
  • Laitinen OH, Honkanen H, Pakkanen O, Coxsackievirus B1 is associated with the induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes 2014;63(2):446–455.
  • Oikarinen S, Tauriainen S, Hober D, Virus Antibody Survey in Different European Populations Indicates Risk Association Between Coxsackievirus B1 and Type 1 Diabetes. Diabetes 2014;63(2):655–662.
  • Cabrera-Rode E, Sarmiento L, Tiberti C, Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16. Diabetologia 2003;46:1348–1353.
  • Pankuweit S, Klingel K. Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev 2013;18(6):683–702.
  • Lévêque N, Renois F, Talmud D, Quantitative genomic and antigenomic enterovirus RNA detection in explanted heart tissue samples from patients with end-stage idiopathic dilated cardiomyopathy. J Clin Microbiol 2012;50:3378–3380.
  • Tauriainen S, Oikarinen S, Oikarinen M, Hyoty H. Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol 2011;33:45–55.
  • Hober D, Sane F, Jaidane H, Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes. Clin Exp Immunol 2012;168:47–51.
  • Marttila J, Juhela S, Vaarala O, Responses of coxsackievirus B4-specific T-cell lines to 2C protein-characterization of epitopes with special reference to the GAD65 homology region. Virology 2001;284:131–141.
  • Kaufman DL, Erlander MG, Clare-Salzler M, Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992;89(1):283–292.
  • Marttila J, Juhela S, Vaarala O, Responses of coxsackievirus B4-specific T-cell lines to 2C protein-characterization of epitopes with special reference to the GAD65 homology region. Virology 2001;284(1):131–141.
  • Atkinson MA, Bowman MA, Campbell L, Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994;94(5):2125–2129.
  • Schloot NC, Willemen SJ, Duinkerken G, Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart. Hum Immunol 2001;62(4):299–309.
  • Lönnrot M, Hyöty H, Knip M, Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of coxsackievirus B4. Childhood Diabetes in Finland Study Group. Clin Exp Immunol 1996;104(3):398–405.
  • Härkönen T, Paananen A, Lankinen H, Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans. J Med Virol 2003;69(3):426–440.
  • Honeyman MC, Stone NL, Falk BA, Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J Immunol 2010;184(4):2204–2210.
  • Bitti ML, Masala S, Capasso F, Mycobacterium avium subsp. paratuberculosis in an Italian cohort of type 1 diabetes pediatric patients. Clin Dev Immunol 2012;2012:785262.
  • Naser SA, Thanigachalam S, Dow CT, Collins MT. Exploring the role of Mycobacterium avium subspecies paratuberculosis in the pathogenesis of type 1 diabetes mellitus: a pilot study. Gut Pathog 2013;5(1):14.
  • Coppieters KT, Wiberg A, von Herrath MG. Viral infections and molecular mimicry in type 1 diabetes. APMIS 2012;120(12):941–949.
  • Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Enterovirus surveillance–United States, 1970–2005. MMWR Surveill Summ 2006;55:1–20.
  • Sadeharju K, Knip M, Virtanen SM, Maternal antibodies in breast milk protect the child from enterovirus infections. Pediatrics 2007;119:941–946.
  • Sadeharju K, Knip M, Hiltunen M, The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens. Diabetologia 2003;46:1100–1105.
  • Tamori A, Gawada M. HLA class II associated with outcomes of hepatitis B and C infections. World J Gastroenterol 2013;19:5395–5401.
  • Mäkelä S, Mustonen J, Ala-Houhala I, Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J Infect Dis 2002;186:843–846.
  • Rother KI, Brown RJ, Morales MM, Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes. Diabetes Care 2009;32:1250–1255.
  • Koivisto VA, Aro A, Cantell K, Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy. Diabetologia 1984;27:193–197.
  • Henke A, Jarasch N, Wutzler P. Vaccination procedures against Coxsackievirus-induced heart disease. Expert Rev Vaccines 2003;2:805–815.
  • Graham S, Wang EC, Jenkins O, Borysiewicz LK. Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. J Virol 1993;67:1627–1637.
  • Seppala E, Viskari H, Hoppu S, Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media. Vaccine 2011;29:8615–8618.
  • Davydova B, Harkonen T, Kaialainen S, Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice. J Med Virol 2003;69:510–520.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.